Looking forward for AMDA to get FDA Clearance for their CASCADE study, a blinded, randomized clinical trial that compared outcomes of cervical fusion between Amedica’s composite silicon nitride devices manufactured with an integrated core of cancellous structured ceramic (CsC), to the existing standard, i.e., PEEK (polyether ether ketone plastic) spacers filled with bone autograft. This will be a huge turning point toward the next phase, manufacturing, marketing and sales.